Figure 1From: Local prostate cancer radiotherapy after prostate-specific antigen progression during primary hormonal therapyOverall survival after EBRT as single modality. (p<0.001 comparing PSA progression during initial HT vs. no PSA progression/no HT in log-rank test).Back to article page
